BRIEF-Zeltia says FDA extends deadline for priority review of Yondelis

<span id="midArticle_start"/>May 5 (Reuters) - Zeltia SA :

<span id="midArticle_0"/>* Says US FDA (Food and Drug Administration) extends bythree months the deadline for completion of priority review ofthe application for Yondelis registration

<span id="midArticle_1"/>* New deadline for priority review of Yondelis for thetreatment of soft tissue sarcoma is Oct. 24Source text for Eikon:

<span id="midArticle_2"/>
<span id="midArticle_3"/>Further company coverage: (Gdynia Newsroom)

<span id="midArticle_4"/>

via Smart Health Shop Forum http://ift.tt/1GXm8Tt